engleski

Re: Xiao et al.: Randomized controlled trial of a dichoptic digital therapeutic for amblyopia (Ophthalmology. 2022;129:77–85)

To The Editor: Xiao et al1 defined a clinically significant vision improvement associated with the use of a digital therapeutic for the treatment of amblyopia from anisometropia, strabismus, or both. The primary outcome was set as the difference in visual acuity (VA) of 0.75 lines. Visual acuity improvement from the therapeutic plus glasses over continued glasses alone was 1 line over 12 weeks. The benefit might be highly important because currently none of the alternative therapeutic modalities have supplanted occlusion. Stereoacuity was not improved.

Ophthalmology ; Amblyopia ; Therapeutics

nije evidentirano